T86.23 Heart transplant infection

Name of the Condition

• Heart transplant infection

Summary

Heart transplant infection refers to infectious complications that occur after a heart transplant, affecting the transplanted organ or surrounding tissues. These infections can arise from bacterial, viral, or fungal sources and may impact graft function, patient recovery, or long-term outcomes. Prompt identification and management are critical to minimize morbidity and support graft survival.

Causes

Infections may result from surgical site exposure, immunosuppressive therapy reducing host defenses, or reactivation of latent pathogens. Common sources include bacterial contamination during surgery, viral infections (e.g., cytomegalovirus), or fungal organisms (e.g., Candida) that exploit weakened immunity. Donor-derived infections or post-transplant exposure to pathogens can also contribute.

Risk Factors

• Immunosuppressive therapy (e.g., calcineurin inhibitors, steroids)
• Prolonged hospitalization or intensive care unit stay
• Pre-existing infections or comorbidities (e.g., diabetes)
• Surgical complications (e.g., wound dehiscence, graft ischemia)
• Mismatched donor-recipient compatibility or prior rejection episodes

Symptoms

• Fever or chills
• Pain, redness, or drainage at the surgical site
• Shortness of breath or chest discomfort
• Fatigue or malaise
• Unexplained weight loss
• Signs of systemic infection (e.g., tachycardia, hypotension)

Diagnosis

Diagnosis involves clinical assessment, imaging (e.g., echocardiogram, CT), and laboratory testing (e.g., blood cultures, viral PCR). Tissue biopsies or fluid analysis may identify specific pathogens. Monitoring for graft dysfunction (e.g., reduced ejection fraction) and inflammatory markers (e.g., CRP) supports early detection.

Treatment Options

Treatment targets the underlying pathogen with appropriate antimicrobials (antibiotics, antivirals, or antifungals). Supportive care includes managing immunosuppression levels, surgical debridement for localized infections, and graft monitoring. Adjunct therapies (e.g., immunoglobulins) may be used in severe cases.

Prognosis and Follow-Up

Prognosis depends on infection type, timing, and graft involvement. Early intervention improves outcomes, but severe or recurrent infections may threaten graft survival. Follow-up includes regular monitoring of organ function, infection recurrence, and immunosuppression efficacy.

Complications

• Graft dysfunction or failure
• Sepsis or systemic inflammatory response
• Rejection due to altered immunosuppression
• Chronic infection (e.g., viral persistence)
• Surgical site complications (e.g., abscess, fistula)

Lifestyle & Prevention

• Strict adherence to antimicrobial prophylaxis
• Hand hygiene and infection control practices
• Avoiding exposure to high-risk environments (e.g., crowds, sick contacts)
• Prompt reporting of symptoms to the transplant team
• Maintaining immunosuppression as prescribed

When to Seek Professional Help

Seek immediate care for fever, worsening pain, shortness of breath, or signs of systemic infection. Contact the transplant team for any new or persistent symptoms, as early intervention is critical.

Tips for Medical Coders

Code T86.23 is specific to infections complicating a heart transplant. Document the infection type (e.g., bacterial, viral, fungal), timing (early vs. late post-transplant), and any associated graft dysfunction. Ensure clear differentiation from other transplant complications (e.g., rejection) to support accurate coding.